글로벌 고혈압 치료 시장 – 2028년까지의 산업 동향 및 예측

시장 분석 및 통찰력: 글로벌 고혈압 치료 시장

고혈압 치료 시장은 2021년부터 2028년까지의 예측 기간 동안 10%의 시장 성장을 목격할 것으로 예상됩니다. 고혈압 치료 시장에 대한 Data Bridge Market Research 보고서는 예측 기간 내내 만연할 것으로 예상되는 다양한 요인에 대한 분석과 통찰력을 제공하고 시장 성장에 미치는 영향을 제공합니다. 고혈압에 대한 인식 증가로 고혈압 치료 시장 성장이 가속화되고 있습니다.

고혈압은 동맥벽 에 대한 혈압이 높은 상태를 말합니다. 이는 심장병의 위험으로 이어질 수 있습니다.

예측 기간 동안 고혈압 치료 시장 성장을 촉진할 것으로 예상되는 주요 요인은 혈압 환자 발생률의 증가입니다. 나아가, 고령화 인구의 증가는 고혈압 치료 시장 성장을 더욱 촉진할 것으로 예상됩니다. 반면에, 약물 승인을 위한 엄격한 규제 절차는 타임라인 기간 동안 고혈압 치료 시장 성장을 더욱 방해할 것으로 예상됩니다.

또한 정부와 민간 기관의 증가 이니셔티브는 향후 몇 년 동안 고혈압 치료 시장 성장에 대한 잠재적 기회를 더욱 제공할 것입니다. 그러나 의약품 및 기타 의료 서비스 비용의 상승은 가까운 미래에 고혈압 치료 시장 성장에 더욱 도전이 될 수 있습니다.

This high blood pressure treatment market report provides details of new recent developments, trade regulations, import export analysis, production analysis, value chain optimization, market share, impact of domestic and localised market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographic expansions, technological innovations in the market. To gain more info on high blood pressure treatment market contact Data Bridge Market Research for an Analyst Brief, our team will help you take an informed market decision to achieve market growth. 

Global High Blood Pressure Treatment Services Market Scope and Market Size

The high blood pressure treatment market is segmented on the basis of type, drug type and distribution channel. The growth amongst these segments will help you analyse meagre growth segments in the industries, and provide the users with valuable market overview and market insights to help them in making strategic decisions for identification of core market applications. 

• On the basis of type, the high blood pressure treatment market is segmented into Systemic Hypertension Drugs and Pulmonary Hypertension Drugs.
• On the basis of drug type, the high blood pressure treatment market is segmented into angiotensin converting enzyme (ACE) inhibitor, diuretic and angiotensin II receptor blockers.
• On the basis of distribution channel, the high blood pressure treatment market is segmented into hospital pharmacies, retail pharmacies, drug stores, online pharmacies.

High Blood Pressure Treatment Services Market Country Level Analysis

The high blood pressure treatment market is segmented on the basis of type, drug type and distribution channel.      

The countries covered in the high blood pressure treatment market report are the U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America.

Asia-Pacific dominates the high blood pressure treatment market due to the rise in the incidence of cardiac diseases. Furthermore, the unhealthy lifestyle choices like smoking, poor diet and increase in the incidence of diabetes and hypertension will further boost the growth of the high blood pressure treatment market in the region during the forecast period. North America is projected to observe significant amount of growth in the high blood pressure treatment market due to the rise in the incidence rate of cardiovascular diseases. Moreover, the increase in the disposable income of the patient population is further anticipated to propel the growth of the high blood pressure treatment market in the region in the coming years.

The country section of the high blood pressure treatment market report also provides individual market impacting factors and changes in regulation in the market domestically that impacts the current and future trends of the market. Data points such as consumption volumes, production sites and volumes, import export analysis, price trend analysis, cost of raw materials, down-stream and upstream value chain analysis are some of the major pointers used to forecast the market scenario for individual countries. Also, presence and availability of global brands and their challenges faced due to large or scarce competition from local and domestic brands, impact of domestic tariffs and trade routes are considered while providing forecast analysis of the country data.

Healthcare Infrastructure growth Installed base and New Technology Penetration

The high blood pressure treatment market also provides you with detailed market analysis for every country growth in healthcare expenditure for capital equipment, installed base of different kind of products for high blood pressure treatment market, impact of technology using life line curves and changes in healthcare regulatory scenarios and their impact on the high blood pressure treatment market. The data is available for historic period 2010-2019.

Competitive Landscape and High Blood Pressure Treatment Services Market Share Analysis

The high blood pressure treatment market competitive landscape provides details by competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, global presence, production sites and facilities, production capacities, company strengths and weaknesses, product launch, product width and breadth, application dominance. The above data points provided are only related to the companies’ focus related to high blood pressure treatment market.

고혈압 치료 시장 보고서에 포함된 주요 기업으로는 AstraZeneca, Boehringer Ingelheim International GmbH, DAIICHI SANKYO COMPANY, LIMITED, Johnson & Johnson Services, Inc., Lupin Pharmaceuticals, Inc., Merck & Co., Inc., Novartis AG, Pfizer Inc., Sun Pharmaceutical Industries Ltd, Sanofi, GlaxoSmithKline plc, Actelion Pharmaceuticals Ltd, United Therapeutics Corporation, Gilead Sciences, Inc., Bayer AG, F. Hoffmann-La Roche Ltd, Abbott, Takeda Pharmaceutical Company Limited, Bausch Health, Lilly 등이 있습니다. 시장 점유율 데이터는 글로벌, 북미, 유럽, 아시아 태평양(APAC), 중동 및 아프리카(MEA), 남미에 대해 각각 제공됩니다. DBMR 분석가는 경쟁 우위를 이해하고 각 경쟁자에 대한 경쟁 분석을 개별적으로 제공합니다.

SKU-46719